Polymorphism screening of PIK4CA: Possible candidate gene for chromosome 22q11-linked psychiatric disorders

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 116 B, Issue 1, 2003, Pages 77-83

  Saito, Takuya ^a   Stopkova, Pavla ^a   Diaz, Libna ^a   Papolos, Demitri F ^a   Boussemart, Lise ^a   Lachman, Herbert M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Candidate gene; Case control; Pleckstrin; VCFS; Velo cardio facial

Indexed keywords

LITHIUM; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE;

ALLELE; ARTICLE; BIPOLAR DISORDER; CHROMOSOME 10P; CHROMOSOME 18Q; CHROMOSOME 21Q; CHROMOSOME 22Q; COMPETITIVE INHIBITION; CONSENSUS SEQUENCE; DEPHOSPHORYLATION; GENE; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MENTAL DISEASE; PIK4CA GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SYNAPSE VESICLE;

EID: 0042827374     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.10042     Document Type: Article

References (52)

1. Berrettini WH. 2000. Susceptibility loci for bipolar disorder: overlap with inherited vulnerability to schizophrenia. Biol Psychiatry 47:245-251.
2. Berrettini WH, Ferraro TN, Goldin LR, Weeks DE, Detera-Wadleigh S, Nurnberger JI Jr, Gershon ES. 1994. Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. Proc Natl Acad Sci USA 91:5918-5921.
3. Berridge MJ, Irvine RF. 1989. Inositol phosphates and cell signaling. Nature 341:197-205.
4. Brzustowicz LM, Hodgkinson K, Chow EW, Honer WG, Bassett AS. 2000. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science 288:678-682.
5. Cremona O, DeCamilli P. 2001. Phosphoinositide in membrane traffic at the synapse. J Cell Sci 114:104-105.
6. Cremona O, Di Paolo G, Wenk MR, Luthi A, Kim WT, Takei K, et al. 1999. Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99:179-188.
7. DeCamilli P, Takei K. 1996. Molecular mechanisms in synaptic vesicle endocytosis and recycling. Neuron 16:481-486.
8. De Luca A, Pasini A, Amati F, Botta A, Spalletta G, Alimenti S, Caccamo F, Conti E, Trakalo J, Macciardi F, Dallapicalla B, Novelli G. 2001. Association study of a promoter polymorphism of UFD1L gene with schizophrenia. Am J Med Genet 105:529-533.
9. Detera-Wadleigh SD, Badner JA, Yoshikawa T, Sanders AR, Goldin LR, Turner G, Rollins DY, Moses T, Guroff JJ, Kazuba D, Maxwell ME, Edenberg HJ, Foroud T, Lahiri D, Nurnberger JI, Stine OC, McMahon F, Meyers DA, MacKinnon D, Simpson S, McInnis M, dePaulo JR, Rice J, Goate A, Gershon ES. 1997. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet 74:254-262.
10. Eberhard DA, Cooper CL, Low MG, Holz RW. 1990. Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. Biochem J 268:15-25.
11. Egan MF, Goldberg TE, Kolachana BS, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
12. Ewald H, Mors O, Koed K, Eiberg H, Kruse TA. 1997. Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families. Psychiatr Genet 7:1-12.
13. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, HarKavy-Friedman J, Friedman J, Kaufmann C, Cloninger CR, Tsuang MT. 1998. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 81:290-295.
14. Foroud T, Castelluccio PF, Koller DL, Edenberg HJ, Miller M, Bowman E, Rau NL, Smiley C, Rice JP, Goate A, Armstrong C, Bierut LJ, Reich T, Detera-Wadleigh SD, Goldin LR, Badner JA, Guroff JJ, Gershon ES, McMahon FJ, Simpson S, MacKinnon D, McInnis M, Stine OC, DePaulo JR, Blehar MC, Nurnberger JI Jr. 2000. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet 96:18-23.
15. Funaki M, Katagiri H, Inukai K, Kikuchi M, Asano T. 2000. Structure and function of phosphatidylinositol-3,4 kinase. Cell Signal 12:135-142.
16. Gehrmann T, Heilmeyer LMG. 1998. Phosphatidylinositol 4-kinases. Eur J Biochem 253:357-370.
17. Gershon ES. 2000. Bipolar illness and schizophrenia as oligogenic diseases: implications for the future. Biol Psychiatry 47:240-247.
18. Gogos JA, Santha M, Takacs Z, Beck KD, Luine V, Lucas LR, Nadler JV, Karayiorgou M. 1999. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet 21:434-439.
19. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R, Fananas L. 1997. Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 154:113-115.
20. Hallcher L, Sherman WR. 1980. The effects of lithium and other agents on the activity of myo-inositiol-1-phosphatase from bovine brain. J Biol Chem 261:8100-8130.
21. Holz RW, Hlubek MD, Sorensen SD, Fisher SK, Balla T, Ozaki S, Prestwich GD, Stuenkel EL, Bittner MA. 2000. A pleckstrin homology domain specific for phosphatidylinositol 4,5-bisphosphate (PtdIns-4,5-P2) and fused to green fluorescent protein identifies plasma membrane PtdIns-4,5-P2 as being important in exocytosis. J Bio Chemistry 275:17878-17885.
22. Ketterling RP, Drost JB, Scaringe WA, Liao D-Z, Liu J-Z, Kasper CK, Sommer SS. 1999. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations. Hum Mutat 13:221-231.
23. Kirov G, Murphy KC, Arranz MJ, Jones I, McCandles F, Kunugi H, Murray RM, McGuffin P, Collier DA, Owen MJ, Craddock N. 1998. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry 3:346-349.
24. Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I, Nemanov L, Ebstein RP. 1999. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activity. Am J Med Genet 88:628-633.
25. Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, Ball D, Arranz MJ, Murray RM, Collier DA. 1997. No evidence for an association of affective disorders with high- or low-activity allele of catechol-O-methyltransferase gene. Biol Psychiatry 42:282-285.
26. Lachman HM, Kelsoe JR, Remick RA, Sadovnick AD, Rapaport MH, Lin M, Pazur BA, Roe AM, Saito T, Papolos DF. 1997a. Linkage studies support a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome. Am J Med Genet 74:121-128.
27. Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia S, Faedda G, Goldberg R, Kucherlapati R, Papolos DF. 1997b. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo cardio facial syndrome. Am J Med Genet 67:468-472.
28. Lachman HM, Kelsoe J, Moreno L, Katz S, Papolos DF. 1997c. No evidence for linkage of COMT polymorphism in bipolar disorder. Psychiatr Genet 7:13-17.
29. Lachman HM, Nolan K, Mohr P, Saito T, Volavka J. 1998. Association between COMT genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155:835-837.
30. Liu J, Juo SH, Terwilliger JD, Grunn A, Tong X, Brito M, Loth JE, Kanyas K, Lerer B, Endicott J, Penchaszadeh G, Gilliam TC, Baron M. 2001. A follow-up study supports evidence for a bipolar affective disorder locus on chromosome 21q22. Am J Med Genet 105:189-194.
31. McPherson PS, Garcia EP, Slepnev VI, David C, Zhang X, Grabs D, et al. 1996. A presynaptic inositol-5-phosphatase. Nature 379:353-357.
32. Moises HW, Yang L, Li T, Havsteen B, Fimmers R, Baur MP, Liu X, Gottesman II. 1995. Potential linkage disequilibrium between schizophrenia and locus D22S278 on the long arm of chromosome 22. Am J Med Genet 60:465-467.
33. Morrow B, Goldberg R, Carlson C, Gupta RD, Sirotkin H, Collins J, Dunham I, O'Donnell H, Scrambler P, Shprintzen RJ, Kucherlapati R. 1995. Molecular definition of the 22q11 deletions in velo-cardio facial syndrome. Am J Hum Genet 56:1391-1403.
34. Murphy KC, Jones LA, Owen MJ. 1999. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 56:940-945.
35. Nishizuka Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
36. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. 1989. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770.
37. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM. 1998. Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 3:342-345.
38. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G. 1994. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12-q13.1: Part 1. Am J Med Genet 54:36-43.
39. Reynolds AJ, Heydon K, Bartlett SE, Hendry IA. 1999. Evidence for phosphatidylinositol 4-kinase and actin involving in the regulator of 121I be to active growth factor retrograde uronat trans. J Neuro Chem 73:87-95.
40. Saito T, Guan F, Papolos DF, Lau S, Klein M, Fann CSJ, Lachman HM. 2001a. Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder. Mol Psychiatry 6:387-395.
41. Saito T, Guan F, Papolos DF, Namouria N, Lachman HM. 2001b. Analysis of SNAP-29, a candidate gene for 22q11-linked psychiatric disorders. Mol Psychiatry 6:193-201.
42. Scambler P, Kelly D, Lindsay E, Williamson R, Goldberg R, Shprintzen R, Wilson DI. 1992. Velo cardio facial syndrome associated with chromosome 22q11 deletions encompassing the DiGeorge Locus. Lancet 339:1138-1139.
43. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K, Segman R, Borrman M, Dreikorn B, Lichtermann D, Rietschel M, Trixler M, Maier W, Wildenauer DB. 1998. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 81:302-307.
44. Searl TJ, Silinsky EM. 2000. The phosphatidylinositol 4-kinase inhibitor phenylarsine oxide blocks evoked neurotransmitter release by reducing calcium entry through N-type calcium channels. Br J Pharmacol 130:418-424.
45. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV, Young D. 1978. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 15:56-62.
46. Sorensen SD, Linseman D, McEwen EL, Heacock AM, Fisher SK. 1998. A role for a Wortmannin-sensitive phosphatidylinositol 4-kinase in neurotransmitter release. J Neurosci 18:5594-5602.
47. Spitzer RL, Endicott J, Robins E. 1978. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35:773-782.
48. Straub RE, Lehner T, Luo Y, Loth JE, Shao W, Sharpe L, et al. 1994. A possible vulnerability locus for BP affective disorder on chromosome 21. Nat Genet 8:291-296.
49. Strous RD, Bark N, Woerner M, Lachman HM. 1997b. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41:493-495.
50. Wei J, Hemmings GP. 1999. Lack of evidence for association between the COMT locus and schizophrenia. Psychiatr Genet 9:183-186.
51. Wiedemann C, Schafer T, Burger MM, Sihra TS. 1998. An essential role for a small vesicle-associated phosphatidylinositol 4-kinase in neurotransmitter release. J Neurosci 18:5594-5602.
52. Yoshikawa T, Padigaru M, Karkera JD, Sharma M, Berrettini WH, Esterling LE, Detera-Wadleigh SD. 2000. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol Psychiatry 5:165-171.